Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 12Terminated 4Completed 4Withdrawn 3Not yet recruiting 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Tissue Banks × Clear all
NCT04305366 2026-02-24

MicroRNA Markers in Head and Neck Cancers

University of Colorado, Denver

Active not recruiting
225 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04223102 2023-08-02

Microbiome and Rectal Cancer

University of South Florida

Phase NA Active not recruiting
40 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡